Elise Call
Physician Assistant · Las Vegas, NVNPI 1174946701
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 210 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,198 and has fallen 53.5% since, to $557 in 2025.
Across 210 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$866
- UCB, Inc.$675
- AbbVie$647
- Novartis$496
- E.r. Squibb & Sons, L.L.C.$493
- ANI Pharmaceuticals, Inc.$246
- plus $725 from 13 others
What the payments were for
- Food & beverage$4,05898%
- Education$902%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 48 | $866 |
| UCB, Inc. | 25 | $675 |
| AbbVie | 36 | $647 |
| Novartis | 25 | $496 |
| E.r. Squibb & Sons, L.L.C. | 36 | $493 |
| ANI Pharmaceuticals, Inc. | 10 | $246 |
| Johnson & Johnson | 9 | $226 |
| Aurinia Pharma U.S., Inc. | 1 | $125 |
| AstraZeneca(2 entities) | 4 | $82 |
| Kyowa Kirin, Inc. | 3 | $66 |
| Sobi, Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Pfizer | 2 | $35 |
| Genentech USA, Inc. | 1 | $27 |
| GSK | 2 | $25 |
| Boehringer Ingelheim | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Sandoz | 1 | $14 |
How this compares
$4,148 in reported general payments places this provider in the 85th percentile of 881 physician assistant providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 16 | $139,325 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Las Vegas
- Steven HawkesLas Vegas$70K
- Nathan MorganLas Vegas$44K
- Stephanie DastrupLas Vegas$23K
- Sandra OviedoLas Vegas$21K
- Patrick JamesonLas Vegas$20K
- Jordan ChristensenLas Vegas$19K
- Jacquelyn DaneshforouzLas Vegas$18K
- Violet AmirjalaliLas Vegas$15K
- Joseph GuruleLas Vegas$15K
- Rebecca Markin-NewsomeLas Vegas$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.